Vivo Opportunity Fund Holdings, L.P.

Related Filers (23)

Ownership (24)

SC 13G
Wednesday, 2/14/2024
Adverum Biotechnologies, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
Gracell Biotechnologies Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
DELCATH SYSTEMS, INC.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
Clene Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
Rezolute, Inc.: Major Shareholders
4
Wednesday, 11/22/2023
Bolt Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/20/2023
Bolt Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 10/13/2023
Rezolute, Inc.: Major Shareholders
SC 13D/A
Wednesday, 10/11/2023
SOLENO THERAPEUTICS INC: Major Shareholders
4
Wednesday, 10/4/2023
SOLENO THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 9/28/2023
SOLENO THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 8/25/2023
COMPASS Pathways plc: Major Shareholders
SC 13G
Friday, 8/18/2023
Gracell Biotechnologies Inc.: Major Shareholders
4
Thursday, 8/10/2023
IO Biotech, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 7/14/2023
Unicycive Therapeutics, Inc.: Major Shareholders
SC 13G
Wednesday, 6/28/2023
Clene Inc.: Major Shareholders
SC 13G
Thursday, 6/22/2023
DELCATH SYSTEMS, INC.: Major Shareholders
SC 13D
Thursday, 6/1/2023
SOLENO THERAPEUTICS INC: Major Shareholders
SC 13G
Monday, 5/15/2023
SOLENO THERAPEUTICS INC: Major Shareholders
3
Monday, 5/15/2023
SOLENO THERAPEUTICS INC: Initial statement of beneficial ownership of securities
4
Friday, 12/23/2022
Terns Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/8/2022
Terns Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/16/2022
Terns Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/1/2022
Sierra Oncology, Inc.: Statement of changes in beneficial ownership of securities
Show More